ACI Limited

aci-bd.com

ACI is one of the leading diversified conglomerates in Bangladesh performing businesses in various areas of Pharmaceuticals, Consumer Brands and Commodity Products, Agribusinesses and Retail Chain Shops with a mission to improve the Quality of life of the people of Bangladesh.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET, PHARMA TECH

GOODRX EXPANDS PHARMACY SERVICES PLATFORM WITH $150M VITACARE ACQUISITION

GoodRx | October 21, 2022

news image

To circumvent overpriced prescription drugs and grow its robust pharmacy services platform, GoodRx finalized its vitaCare acquisition. Based on a transaction that started in the first quarter of 2022, GoodRx agreed to secure vitaCare for $150 million in cash. Based on vitaCare’s financial performance through 2023, an additional $7 million consideration is also possible. Read More

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

news image

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More

CHALLENGES FOR TRANSLATING PHARMACOMICROBIOMICS TO PERSONALIZED MEDICINE

News-Medical.Net | March 02, 2020

news image

A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.Pharmacomicrobiomics is the study of how microbiome variations within and between individuals affect drug action, efficacy, and toxicity. This personalized medicine horizon scanning is featured in OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Ramy Aziz and Marwa ElRakaiby, Cairo Univer...

Read More

Business Insights

APTAR EXPANDS PHARMACEUTICAL SERVICES ANNOUNCES EXCLUSIVE COLLABORATION BETWEEN APTAR PHARMA AND FLUIDDA

Aptar Pharma and Fluidda | September 23, 2022

news image

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration approvals for orally inhaled generic products via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar in...

Read More
news image

PHARMACY MARKET, PHARMA TECH

GOODRX EXPANDS PHARMACY SERVICES PLATFORM WITH $150M VITACARE ACQUISITION

GoodRx | October 21, 2022

To circumvent overpriced prescription drugs and grow its robust pharmacy services platform, GoodRx finalized its vitaCare acquisition. Based on a transaction that started in the first quarter of 2022, GoodRx agreed to secure vitaCare for $150 million in cash. Based on vitaCare’s financial performance through 2023, an additional $7 million consideration is also possible. Read More

news image

Pharmacy Market

MEDNOW ANNOUNCES PHARMACY PARTNERSHIP AGREEMENT WITH SERVICEPLUS, A NATIONAL TOTAL REWARDS PLATFORM OPERATED BY PIPSC

Businesswire | June 20, 2023

Mednow Inc. Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has executed a Preferred Pharmacy Agreement with ServicePlus, a leading provider of Member Benefit and rewards services. The agreement allows ServicePlus members to leverage enhanced services and preferred pricing from Mednow digital pharmacy and healthcare platform to its clients and plan members. "Mednow is thrilled to partner with ServicePlus to expand access to virtual pharmac...

Read More
news image

CHALLENGES FOR TRANSLATING PHARMACOMICROBIOMICS TO PERSONALIZED MEDICINE

News-Medical.Net | March 02, 2020

A new Commentary identifies three actionable challenges for translating pharmacomicrobiomics to personalized medicine in 2020.Pharmacomicrobiomics is the study of how microbiome variations within and between individuals affect drug action, efficacy, and toxicity. This personalized medicine horizon scanning is featured in OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers. Ramy Aziz and Marwa ElRakaiby, Cairo Univer...

Read More
news image

Business Insights

APTAR EXPANDS PHARMACEUTICAL SERVICES ANNOUNCES EXCLUSIVE COLLABORATION BETWEEN APTAR PHARMA AND FLUIDDA

Aptar Pharma and Fluidda | September 23, 2022

Nanopharm, an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products announced an exclusive collaboration with Fluidda, a leader in the field of Functional Respiratory Imaging. The companies will leverage their respective proprietary technology platforms to help accelerate U.S. Food & Drug Administration approvals for orally inhaled generic products via the alternative bioequivalence pathway. Nanopharm was acquired by Aptar in...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us